G9a is involved in the regulation of cranial bone formation through activation of Runx2 function during development
The methyltransferase G9a was originally isolated as a histone methyltransferase that catalyzes the methylation of histone 3 lysine 9 (H3K9) to a dimethylated state (H3K9me2). Recent studies have revealed that G9a has multiple functions in various cells, including osteoblasts. Here, we investigated...
Gespeichert in:
Veröffentlicht in: | Bone (New York, N.Y.) N.Y.), 2020-08, Vol.137, p.115332-115332, Article 115332 |
---|---|
Hauptverfasser: | , , , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 115332 |
---|---|
container_issue | |
container_start_page | 115332 |
container_title | Bone (New York, N.Y.) |
container_volume | 137 |
creator | Ideno, Hisashi Nakashima, Kazuhisa Komatsu, Koichiro Araki, Ryoko Abe, Masumi Arai, Yoshinori Kimura, Hiroshi Shinkai, Yoichi Tachibana, Makoto Nifuji, Akira |
description | The methyltransferase G9a was originally isolated as a histone methyltransferase that catalyzes the methylation of histone 3 lysine 9 (H3K9) to a dimethylated state (H3K9me2). Recent studies have revealed that G9a has multiple functions in various cells, including osteoblasts. Here, we investigated G9a function during cranial bone formation. Crossing Sox9-cre with G9aflox/flox (fl/fl) mice generated conditional knockout mice lacking G9a expression in Sox9-positive neural crest-derived bone cells. Sox9-Cre/G9afl/fl mice showed severe hypo-mineralization of cranial vault bones, including defects in nasal, frontal, and parietal bones with opened fontanelles. Cell proliferation was inhibited in G9a-deleted calvarial bone tissues. Expression levels of bone marker genes, i.e., alkaline phosphatase and osteocalcin, were suppressed, whereas Runx2 expression was not significantly decreased in those tissues. In vitro experiments using G9a-deleted calvarial osteoblasts showed decreased cell proliferation after G9a deletion. In G9a-deleted osteoblasts, expression levels of fibroblast growth factor receptors and several cyclins were suppressed. Moreover, the expression of bone marker genes was decreased, whereas Runx2 expression was not altered by G9a deletion in vitro. G9a enhanced the transcriptional activity of Runx2, whereas siRNA targeting G9a inhibited the transcriptional activity of Runx2 in C3H10T1/2 mesenchymal cells. We confirmed the direct association of endogenous Runx2 with G9a. Chromatin immunoprecipitation experiments showed that G9a bound to Runx2-target regions in promoters in primary osteoblasts. Furthermore, Runx2 binding to the osteocalcin promoter was abrogated in G9-deleted osteoblasts. These results suggest that G9a regulates proliferation and differentiation of cranial bone cells through binding to and activating Runx2.
•G9a cKO mice exhibited severe defects cranial vault bones with opened fontanelles.•Proliferation and differentiation were inhibited in G9a-deleted osteoblasts.•G9a binds to endogenous Runx2 and modulate the transcriptional activity of Runx2.•G9a binds to target regions of Runx2 on the genome. |
doi_str_mv | 10.1016/j.bone.2020.115332 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2396307405</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S8756328220301125</els_id><sourcerecordid>2396307405</sourcerecordid><originalsourceid>FETCH-LOGICAL-c466t-79836ef70f2bddcf8a462ac6ae1ad6d0e5ae0f456c230f6b4624ba4a76580b633</originalsourceid><addsrcrecordid>eNp9kE1LxDAQhoMoun78AQ-So5eu-WjTLngR8QsEQfQc0mSym6VN1qQt-u_t2tWjpxnmfeYd5kXonJI5JVRcred18DBnhI0DWnDO9tCMViXPWCn4PppVZSEyzip2hI5TWhNC-KKkh-iIM57nlLAZSg8LhV3Czg-hGcCMDe5WgCMs-0Z1LngcLNZReacavL2HbYjtpHSrGPrlCivdueEPfu39J8O29_pnYvro_BIbGKAJmxZ8d4oOrGoSnO3qCXq_v3u7fcyeXx6ebm-eM50L0WXlouICbEksq43RtlK5YEoLBVQZYQgUCojNC6EZJ1bUo5rXKlelKCpSC85P0OXku4nho4fUydYlDU2jPIQ-ScYXgpMyJ8WIsgnVMaQUwcpNdK2KX5ISuQ1bruX2ebkNW05hj0sXO_--bsH8rfymOwLXEwDjl4ODKJN24DUYF0F30gT3n_83ITqR8Q</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2396307405</pqid></control><display><type>article</type><title>G9a is involved in the regulation of cranial bone formation through activation of Runx2 function during development</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals Complete</source><creator>Ideno, Hisashi ; Nakashima, Kazuhisa ; Komatsu, Koichiro ; Araki, Ryoko ; Abe, Masumi ; Arai, Yoshinori ; Kimura, Hiroshi ; Shinkai, Yoichi ; Tachibana, Makoto ; Nifuji, Akira</creator><creatorcontrib>Ideno, Hisashi ; Nakashima, Kazuhisa ; Komatsu, Koichiro ; Araki, Ryoko ; Abe, Masumi ; Arai, Yoshinori ; Kimura, Hiroshi ; Shinkai, Yoichi ; Tachibana, Makoto ; Nifuji, Akira</creatorcontrib><description>The methyltransferase G9a was originally isolated as a histone methyltransferase that catalyzes the methylation of histone 3 lysine 9 (H3K9) to a dimethylated state (H3K9me2). Recent studies have revealed that G9a has multiple functions in various cells, including osteoblasts. Here, we investigated G9a function during cranial bone formation. Crossing Sox9-cre with G9aflox/flox (fl/fl) mice generated conditional knockout mice lacking G9a expression in Sox9-positive neural crest-derived bone cells. Sox9-Cre/G9afl/fl mice showed severe hypo-mineralization of cranial vault bones, including defects in nasal, frontal, and parietal bones with opened fontanelles. Cell proliferation was inhibited in G9a-deleted calvarial bone tissues. Expression levels of bone marker genes, i.e., alkaline phosphatase and osteocalcin, were suppressed, whereas Runx2 expression was not significantly decreased in those tissues. In vitro experiments using G9a-deleted calvarial osteoblasts showed decreased cell proliferation after G9a deletion. In G9a-deleted osteoblasts, expression levels of fibroblast growth factor receptors and several cyclins were suppressed. Moreover, the expression of bone marker genes was decreased, whereas Runx2 expression was not altered by G9a deletion in vitro. G9a enhanced the transcriptional activity of Runx2, whereas siRNA targeting G9a inhibited the transcriptional activity of Runx2 in C3H10T1/2 mesenchymal cells. We confirmed the direct association of endogenous Runx2 with G9a. Chromatin immunoprecipitation experiments showed that G9a bound to Runx2-target regions in promoters in primary osteoblasts. Furthermore, Runx2 binding to the osteocalcin promoter was abrogated in G9-deleted osteoblasts. These results suggest that G9a regulates proliferation and differentiation of cranial bone cells through binding to and activating Runx2.
•G9a cKO mice exhibited severe defects cranial vault bones with opened fontanelles.•Proliferation and differentiation were inhibited in G9a-deleted osteoblasts.•G9a binds to endogenous Runx2 and modulate the transcriptional activity of Runx2.•G9a binds to target regions of Runx2 on the genome.</description><identifier>ISSN: 8756-3282</identifier><identifier>EISSN: 1873-2763</identifier><identifier>DOI: 10.1016/j.bone.2020.115332</identifier><identifier>PMID: 32344102</identifier><language>eng</language><publisher>United States: Elsevier Inc</publisher><subject>Animals ; Cell Differentiation ; Core Binding Factor Alpha 1 Subunit - genetics ; Cranial bone ; Epigenetics ; Histone methyltransferase ; Histone-Lysine N-Methyltransferase ; Mice ; Osteoblasts ; Osteogenesis ; Promoter Regions, Genetic ; Runx2 ; Skull</subject><ispartof>Bone (New York, N.Y.), 2020-08, Vol.137, p.115332-115332, Article 115332</ispartof><rights>2020 Elsevier Inc.</rights><rights>Copyright © 2020 Elsevier Inc. All rights reserved.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c466t-79836ef70f2bddcf8a462ac6ae1ad6d0e5ae0f456c230f6b4624ba4a76580b633</citedby><cites>FETCH-LOGICAL-c466t-79836ef70f2bddcf8a462ac6ae1ad6d0e5ae0f456c230f6b4624ba4a76580b633</cites><orcidid>0000-0002-8182-4380</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1016/j.bone.2020.115332$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,780,784,3550,27924,27925,45995</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/32344102$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Ideno, Hisashi</creatorcontrib><creatorcontrib>Nakashima, Kazuhisa</creatorcontrib><creatorcontrib>Komatsu, Koichiro</creatorcontrib><creatorcontrib>Araki, Ryoko</creatorcontrib><creatorcontrib>Abe, Masumi</creatorcontrib><creatorcontrib>Arai, Yoshinori</creatorcontrib><creatorcontrib>Kimura, Hiroshi</creatorcontrib><creatorcontrib>Shinkai, Yoichi</creatorcontrib><creatorcontrib>Tachibana, Makoto</creatorcontrib><creatorcontrib>Nifuji, Akira</creatorcontrib><title>G9a is involved in the regulation of cranial bone formation through activation of Runx2 function during development</title><title>Bone (New York, N.Y.)</title><addtitle>Bone</addtitle><description>The methyltransferase G9a was originally isolated as a histone methyltransferase that catalyzes the methylation of histone 3 lysine 9 (H3K9) to a dimethylated state (H3K9me2). Recent studies have revealed that G9a has multiple functions in various cells, including osteoblasts. Here, we investigated G9a function during cranial bone formation. Crossing Sox9-cre with G9aflox/flox (fl/fl) mice generated conditional knockout mice lacking G9a expression in Sox9-positive neural crest-derived bone cells. Sox9-Cre/G9afl/fl mice showed severe hypo-mineralization of cranial vault bones, including defects in nasal, frontal, and parietal bones with opened fontanelles. Cell proliferation was inhibited in G9a-deleted calvarial bone tissues. Expression levels of bone marker genes, i.e., alkaline phosphatase and osteocalcin, were suppressed, whereas Runx2 expression was not significantly decreased in those tissues. In vitro experiments using G9a-deleted calvarial osteoblasts showed decreased cell proliferation after G9a deletion. In G9a-deleted osteoblasts, expression levels of fibroblast growth factor receptors and several cyclins were suppressed. Moreover, the expression of bone marker genes was decreased, whereas Runx2 expression was not altered by G9a deletion in vitro. G9a enhanced the transcriptional activity of Runx2, whereas siRNA targeting G9a inhibited the transcriptional activity of Runx2 in C3H10T1/2 mesenchymal cells. We confirmed the direct association of endogenous Runx2 with G9a. Chromatin immunoprecipitation experiments showed that G9a bound to Runx2-target regions in promoters in primary osteoblasts. Furthermore, Runx2 binding to the osteocalcin promoter was abrogated in G9-deleted osteoblasts. These results suggest that G9a regulates proliferation and differentiation of cranial bone cells through binding to and activating Runx2.
•G9a cKO mice exhibited severe defects cranial vault bones with opened fontanelles.•Proliferation and differentiation were inhibited in G9a-deleted osteoblasts.•G9a binds to endogenous Runx2 and modulate the transcriptional activity of Runx2.•G9a binds to target regions of Runx2 on the genome.</description><subject>Animals</subject><subject>Cell Differentiation</subject><subject>Core Binding Factor Alpha 1 Subunit - genetics</subject><subject>Cranial bone</subject><subject>Epigenetics</subject><subject>Histone methyltransferase</subject><subject>Histone-Lysine N-Methyltransferase</subject><subject>Mice</subject><subject>Osteoblasts</subject><subject>Osteogenesis</subject><subject>Promoter Regions, Genetic</subject><subject>Runx2</subject><subject>Skull</subject><issn>8756-3282</issn><issn>1873-2763</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2020</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9kE1LxDAQhoMoun78AQ-So5eu-WjTLngR8QsEQfQc0mSym6VN1qQt-u_t2tWjpxnmfeYd5kXonJI5JVRcred18DBnhI0DWnDO9tCMViXPWCn4PppVZSEyzip2hI5TWhNC-KKkh-iIM57nlLAZSg8LhV3Czg-hGcCMDe5WgCMs-0Z1LngcLNZReacavL2HbYjtpHSrGPrlCivdueEPfu39J8O29_pnYvro_BIbGKAJmxZ8d4oOrGoSnO3qCXq_v3u7fcyeXx6ebm-eM50L0WXlouICbEksq43RtlK5YEoLBVQZYQgUCojNC6EZJ1bUo5rXKlelKCpSC85P0OXku4nho4fUydYlDU2jPIQ-ScYXgpMyJ8WIsgnVMaQUwcpNdK2KX5ISuQ1bruX2ebkNW05hj0sXO_--bsH8rfymOwLXEwDjl4ODKJN24DUYF0F30gT3n_83ITqR8Q</recordid><startdate>20200801</startdate><enddate>20200801</enddate><creator>Ideno, Hisashi</creator><creator>Nakashima, Kazuhisa</creator><creator>Komatsu, Koichiro</creator><creator>Araki, Ryoko</creator><creator>Abe, Masumi</creator><creator>Arai, Yoshinori</creator><creator>Kimura, Hiroshi</creator><creator>Shinkai, Yoichi</creator><creator>Tachibana, Makoto</creator><creator>Nifuji, Akira</creator><general>Elsevier Inc</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0002-8182-4380</orcidid></search><sort><creationdate>20200801</creationdate><title>G9a is involved in the regulation of cranial bone formation through activation of Runx2 function during development</title><author>Ideno, Hisashi ; Nakashima, Kazuhisa ; Komatsu, Koichiro ; Araki, Ryoko ; Abe, Masumi ; Arai, Yoshinori ; Kimura, Hiroshi ; Shinkai, Yoichi ; Tachibana, Makoto ; Nifuji, Akira</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c466t-79836ef70f2bddcf8a462ac6ae1ad6d0e5ae0f456c230f6b4624ba4a76580b633</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2020</creationdate><topic>Animals</topic><topic>Cell Differentiation</topic><topic>Core Binding Factor Alpha 1 Subunit - genetics</topic><topic>Cranial bone</topic><topic>Epigenetics</topic><topic>Histone methyltransferase</topic><topic>Histone-Lysine N-Methyltransferase</topic><topic>Mice</topic><topic>Osteoblasts</topic><topic>Osteogenesis</topic><topic>Promoter Regions, Genetic</topic><topic>Runx2</topic><topic>Skull</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Ideno, Hisashi</creatorcontrib><creatorcontrib>Nakashima, Kazuhisa</creatorcontrib><creatorcontrib>Komatsu, Koichiro</creatorcontrib><creatorcontrib>Araki, Ryoko</creatorcontrib><creatorcontrib>Abe, Masumi</creatorcontrib><creatorcontrib>Arai, Yoshinori</creatorcontrib><creatorcontrib>Kimura, Hiroshi</creatorcontrib><creatorcontrib>Shinkai, Yoichi</creatorcontrib><creatorcontrib>Tachibana, Makoto</creatorcontrib><creatorcontrib>Nifuji, Akira</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Bone (New York, N.Y.)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Ideno, Hisashi</au><au>Nakashima, Kazuhisa</au><au>Komatsu, Koichiro</au><au>Araki, Ryoko</au><au>Abe, Masumi</au><au>Arai, Yoshinori</au><au>Kimura, Hiroshi</au><au>Shinkai, Yoichi</au><au>Tachibana, Makoto</au><au>Nifuji, Akira</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>G9a is involved in the regulation of cranial bone formation through activation of Runx2 function during development</atitle><jtitle>Bone (New York, N.Y.)</jtitle><addtitle>Bone</addtitle><date>2020-08-01</date><risdate>2020</risdate><volume>137</volume><spage>115332</spage><epage>115332</epage><pages>115332-115332</pages><artnum>115332</artnum><issn>8756-3282</issn><eissn>1873-2763</eissn><abstract>The methyltransferase G9a was originally isolated as a histone methyltransferase that catalyzes the methylation of histone 3 lysine 9 (H3K9) to a dimethylated state (H3K9me2). Recent studies have revealed that G9a has multiple functions in various cells, including osteoblasts. Here, we investigated G9a function during cranial bone formation. Crossing Sox9-cre with G9aflox/flox (fl/fl) mice generated conditional knockout mice lacking G9a expression in Sox9-positive neural crest-derived bone cells. Sox9-Cre/G9afl/fl mice showed severe hypo-mineralization of cranial vault bones, including defects in nasal, frontal, and parietal bones with opened fontanelles. Cell proliferation was inhibited in G9a-deleted calvarial bone tissues. Expression levels of bone marker genes, i.e., alkaline phosphatase and osteocalcin, were suppressed, whereas Runx2 expression was not significantly decreased in those tissues. In vitro experiments using G9a-deleted calvarial osteoblasts showed decreased cell proliferation after G9a deletion. In G9a-deleted osteoblasts, expression levels of fibroblast growth factor receptors and several cyclins were suppressed. Moreover, the expression of bone marker genes was decreased, whereas Runx2 expression was not altered by G9a deletion in vitro. G9a enhanced the transcriptional activity of Runx2, whereas siRNA targeting G9a inhibited the transcriptional activity of Runx2 in C3H10T1/2 mesenchymal cells. We confirmed the direct association of endogenous Runx2 with G9a. Chromatin immunoprecipitation experiments showed that G9a bound to Runx2-target regions in promoters in primary osteoblasts. Furthermore, Runx2 binding to the osteocalcin promoter was abrogated in G9-deleted osteoblasts. These results suggest that G9a regulates proliferation and differentiation of cranial bone cells through binding to and activating Runx2.
•G9a cKO mice exhibited severe defects cranial vault bones with opened fontanelles.•Proliferation and differentiation were inhibited in G9a-deleted osteoblasts.•G9a binds to endogenous Runx2 and modulate the transcriptional activity of Runx2.•G9a binds to target regions of Runx2 on the genome.</abstract><cop>United States</cop><pub>Elsevier Inc</pub><pmid>32344102</pmid><doi>10.1016/j.bone.2020.115332</doi><tpages>1</tpages><orcidid>https://orcid.org/0000-0002-8182-4380</orcidid></addata></record> |
fulltext | fulltext |
identifier | ISSN: 8756-3282 |
ispartof | Bone (New York, N.Y.), 2020-08, Vol.137, p.115332-115332, Article 115332 |
issn | 8756-3282 1873-2763 |
language | eng |
recordid | cdi_proquest_miscellaneous_2396307405 |
source | MEDLINE; Elsevier ScienceDirect Journals Complete |
subjects | Animals Cell Differentiation Core Binding Factor Alpha 1 Subunit - genetics Cranial bone Epigenetics Histone methyltransferase Histone-Lysine N-Methyltransferase Mice Osteoblasts Osteogenesis Promoter Regions, Genetic Runx2 Skull |
title | G9a is involved in the regulation of cranial bone formation through activation of Runx2 function during development |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-01T13%3A27%3A07IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=G9a%20is%20involved%20in%20the%20regulation%20of%20cranial%20bone%20formation%20through%20activation%20of%20Runx2%20function%20during%20development&rft.jtitle=Bone%20(New%20York,%20N.Y.)&rft.au=Ideno,%20Hisashi&rft.date=2020-08-01&rft.volume=137&rft.spage=115332&rft.epage=115332&rft.pages=115332-115332&rft.artnum=115332&rft.issn=8756-3282&rft.eissn=1873-2763&rft_id=info:doi/10.1016/j.bone.2020.115332&rft_dat=%3Cproquest_cross%3E2396307405%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2396307405&rft_id=info:pmid/32344102&rft_els_id=S8756328220301125&rfr_iscdi=true |